GERMANY: BIO-CARE TO LAUNCH EPIGRAFT

Article Abstract:

The first tissue engineering product on the German market will be launched by Bio-Care Biotechnologie fur die Therapie GmbH. The Leipzig-based company developed the technology for the sealing of chronic ulcers in cooperation with the university clinic of Bern. EpiGraft is cultivated out of hair root cells.

Product information, Manufacturing processes

---

GERMANY: HENKEL SUPPORTS TEST KIT DEVELOPER

Article Abstract:

Vermicon AG, a Munich-based company developing test kits for micro-organisms, has got a new partner. The chemicals group Henkel has taken a minority stake in the German company that developed Vermicon Identification Technology (VIT). This technology facilitates the identification of bacteria.

Research & development outlays, Henkel KGAA

---

Germany: BioTissue sole owner of Trans-Tissue

Article Abstract:

Freiburg-based BioTissue Technologies AG has taken over another 37.6% stake in Trans-Tissue Technologies GmbH. With this DM 4.2mn acquisition, BioTissue is the sole owner of the Berlin-based company. Trans-Tissue Technologies, the hived-off unit of Charite (the faculty of medicine of Berlin-based Humbold University), is active in developing tissue replacements of the 2nd generation which are produced naturally in the body.

Health Care and Social Assistance, Surgical Procedures, HEALTH SERVICES, Surgery, BioTissue Technologies AG

Similar abstracts:

• Abstracts: SWITZERLAND: STERITEC BOUGHT BY SULZER INFRATEC. GERMANY: VINTRON INVESTING IN VINYL CHLORIDE. South Africa/Germany: Lurgi, Sasol team up

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.